An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...

Two groundbreaking studies from UC San Francisco (UCSF) are bringing the promise of round-the-clock personalized care for ...

Shawn Connolly, diagnosed with Parkinson’s at 39, took part in a study that personalized deep brain stimulation to his ...

JPM24: FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s, epilepsy and more Medtronic previously ..

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

For people with treatment-resistant depression, traditional medicines and therapy have failed, but Abbott hopes deep brain ...

A novel neurotechnology treatment known as deep brain stimulation (DBS) can benefit patients with neurological disorders, but ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

Body Dementia (LBD) are two devastating neurodegenerative conditions affecting millions of people in the United States. Both ...

The 43-year-old is bringing his own brand of "Sol Power" and tenacity to hopefully make a million-dollar sale.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.